Kailera Therapeutics, Inc. carries a market capitalization of 2.10B, placing it among publicly traded companies globally.
| Market Cap | 2.10B |
| Enterprise Value | N/A |
Kailera Therapeutics, Inc.'s stock has declined approximately -37.57692% over the past 52 weeks. The 50-day moving average sits at 18.60, while the 200-day moving average is 20.27.
| Beta (5Y) | N/A |
| 52-Week Price Change | -37.57692% |
| 50-Day Moving Average | 18.60 |
| 200-Day Moving Average | 20.27 |
| Average Volume (20 Days) | N/A |